Neopenda, PBC
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-08-278/27/26 | New | $215,000 | $215,000 | Debt Only | 06b | SEC linkSEC |
| 2026-05-075/7/26 | New | $35,000 | $35,000 | Debt Only | 06b | SEC linkSEC |
| 2024-11-1811/18/24 | New | $200,000 | $200,000 | Debt Only | 06b | SEC linkSEC |
| 2024-01-031/3/24 | Amended | $700,000 | $200,000 | Debt Only | 06b | SEC linkSEC |
| 2022-09-019/1/22 | New | $500,000 | $500,000 | Debt Only | 06b | SEC linkSEC |
| 2020-06-296/29/20 | New | $252,000 | $252,000 | Debt Only | 06b | SEC linkSEC |
| 2019-03-063/6/19 | New | $410,000 | $410,000 | Debt Only | 06b | SEC linkSEC |
| 2018-08-308/30/18 | New | $20,000 | $20,000 | Equity Only | 06b | SEC linkSEC |
| 2018-08-308/30/18 | New | $125,000 | $125,000 | Debt Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Teresa Cauvel | Director, Executive |
| Zachary Seaverns | Director |
| Sona Shah | Director, Executive |
Industry: Biotechnology (See others in industry)
Address:
1623 W Fulton St
Chicago, IL, 60612
Phone: 919-622-2487
Chicago, IL, 60612
Phone: 919-622-2487